Serum α1-antitrypsin deficiency associated with the common S-type (Glu264 → Val) mutation results from intracellular degradation of α1-antitrypsin prior to secretion

D. T. Curiel, A. Chytil, M. Courtney, Ronald Crystal

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The S-type α1-antitrypsin (α1AT) deficiency allele differs from the normal M1(Val213) allele by a single amino acid substitution (Glu264 → Val). To evaluate the molecular pathophysiology responsible for the reduced serum levels of α1AT associated with the S-type allele, α1AT gene expression was examined in blood monocytes, cells which normally produce α1AT, as well as murine fibroblasts modified by retroviral gene transfer to express the S-type and normal M-type human α1AT geens. Northern analysis and S1 protection analysis demonstrated that monocytes of M and S homozygotes both express 1.8-kilobase α1AT mRNA transcripts in comparable levels and similar in structure. Pulse-chase labeling studies demonstrated that both M and S monocytes synthesized and secreted a 52-kDa protein, but the S monocytes secreted significantly less. The cellular lysates of both M and S monocytes contained a newly synthesized 50-kDa precursor form of α1AT, but the S monocytes contained reduced amounts. Pulse-chase labeling in the presence of tunicamycin, an inhibitor of core oligosaccharide addition, demonstrated that S monocytes exhibited a selective inhibition of secretion of 45-kDa nonglycosylated α1AT not observed in M monocytes. Consistent with these observations, murine fibroblasts modified by retroviral gene transfer to contain as integrated human S-type α1AT cDNA demonstrated reduced secretion of α1AT compared with fibroblasts containing an integrated human M-type α1AT cDNA and also reproduced the abnormality of α1AT biosynthesis observed with S-type monocytes. Furthermore, in the presence of leupeptin, an inhibitor of cellular proteinases, the S-type modified fibroblasts demonstrated a selective augmentation of human α1AT secretion not observed for the M-type. Together, these observations are consistent with the concept that the single A → T mutation of the S-type α1AT gene results in reduced cellular secretion of α1AT because the newly synthesized S-type α1AT protein is degraded intracellularly prior to secretion.

Original languageEnglish
Pages (from-to)10477-10486
Number of pages10
JournalJournal of Biological Chemistry
Volume264
Issue number18
Publication statusPublished - 1 Jan 1989
Externally publishedYes

Fingerprint

Fibroblasts
Monocytes
Gene transfer
Degradation
Mutation
Serum
Labeling
Complementary DNA
Tunicamycin
Protein S
Biosynthesis
Alleles
Oligosaccharides
Gene expression
Blood
Peptide Hydrolases
Substitution reactions
Genes
Amino Acids
Messenger RNA

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Serum α1-antitrypsin deficiency associated with the common S-type (Glu264 → Val) mutation results from intracellular degradation of α1-antitrypsin prior to secretion. / Curiel, D. T.; Chytil, A.; Courtney, M.; Crystal, Ronald.

In: Journal of Biological Chemistry, Vol. 264, No. 18, 01.01.1989, p. 10477-10486.

Research output: Contribution to journalArticle

@article{ac10be01a871471f8a04e5a401c4f30c,
title = "Serum α1-antitrypsin deficiency associated with the common S-type (Glu264 → Val) mutation results from intracellular degradation of α1-antitrypsin prior to secretion",
abstract = "The S-type α1-antitrypsin (α1AT) deficiency allele differs from the normal M1(Val213) allele by a single amino acid substitution (Glu264 → Val). To evaluate the molecular pathophysiology responsible for the reduced serum levels of α1AT associated with the S-type allele, α1AT gene expression was examined in blood monocytes, cells which normally produce α1AT, as well as murine fibroblasts modified by retroviral gene transfer to express the S-type and normal M-type human α1AT geens. Northern analysis and S1 protection analysis demonstrated that monocytes of M and S homozygotes both express 1.8-kilobase α1AT mRNA transcripts in comparable levels and similar in structure. Pulse-chase labeling studies demonstrated that both M and S monocytes synthesized and secreted a 52-kDa protein, but the S monocytes secreted significantly less. The cellular lysates of both M and S monocytes contained a newly synthesized 50-kDa precursor form of α1AT, but the S monocytes contained reduced amounts. Pulse-chase labeling in the presence of tunicamycin, an inhibitor of core oligosaccharide addition, demonstrated that S monocytes exhibited a selective inhibition of secretion of 45-kDa nonglycosylated α1AT not observed in M monocytes. Consistent with these observations, murine fibroblasts modified by retroviral gene transfer to contain as integrated human S-type α1AT cDNA demonstrated reduced secretion of α1AT compared with fibroblasts containing an integrated human M-type α1AT cDNA and also reproduced the abnormality of α1AT biosynthesis observed with S-type monocytes. Furthermore, in the presence of leupeptin, an inhibitor of cellular proteinases, the S-type modified fibroblasts demonstrated a selective augmentation of human α1AT secretion not observed for the M-type. Together, these observations are consistent with the concept that the single A → T mutation of the S-type α1AT gene results in reduced cellular secretion of α1AT because the newly synthesized S-type α1AT protein is degraded intracellularly prior to secretion.",
author = "Curiel, {D. T.} and A. Chytil and M. Courtney and Ronald Crystal",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "264",
pages = "10477--10486",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "18",

}

TY - JOUR

T1 - Serum α1-antitrypsin deficiency associated with the common S-type (Glu264 → Val) mutation results from intracellular degradation of α1-antitrypsin prior to secretion

AU - Curiel, D. T.

AU - Chytil, A.

AU - Courtney, M.

AU - Crystal, Ronald

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The S-type α1-antitrypsin (α1AT) deficiency allele differs from the normal M1(Val213) allele by a single amino acid substitution (Glu264 → Val). To evaluate the molecular pathophysiology responsible for the reduced serum levels of α1AT associated with the S-type allele, α1AT gene expression was examined in blood monocytes, cells which normally produce α1AT, as well as murine fibroblasts modified by retroviral gene transfer to express the S-type and normal M-type human α1AT geens. Northern analysis and S1 protection analysis demonstrated that monocytes of M and S homozygotes both express 1.8-kilobase α1AT mRNA transcripts in comparable levels and similar in structure. Pulse-chase labeling studies demonstrated that both M and S monocytes synthesized and secreted a 52-kDa protein, but the S monocytes secreted significantly less. The cellular lysates of both M and S monocytes contained a newly synthesized 50-kDa precursor form of α1AT, but the S monocytes contained reduced amounts. Pulse-chase labeling in the presence of tunicamycin, an inhibitor of core oligosaccharide addition, demonstrated that S monocytes exhibited a selective inhibition of secretion of 45-kDa nonglycosylated α1AT not observed in M monocytes. Consistent with these observations, murine fibroblasts modified by retroviral gene transfer to contain as integrated human S-type α1AT cDNA demonstrated reduced secretion of α1AT compared with fibroblasts containing an integrated human M-type α1AT cDNA and also reproduced the abnormality of α1AT biosynthesis observed with S-type monocytes. Furthermore, in the presence of leupeptin, an inhibitor of cellular proteinases, the S-type modified fibroblasts demonstrated a selective augmentation of human α1AT secretion not observed for the M-type. Together, these observations are consistent with the concept that the single A → T mutation of the S-type α1AT gene results in reduced cellular secretion of α1AT because the newly synthesized S-type α1AT protein is degraded intracellularly prior to secretion.

AB - The S-type α1-antitrypsin (α1AT) deficiency allele differs from the normal M1(Val213) allele by a single amino acid substitution (Glu264 → Val). To evaluate the molecular pathophysiology responsible for the reduced serum levels of α1AT associated with the S-type allele, α1AT gene expression was examined in blood monocytes, cells which normally produce α1AT, as well as murine fibroblasts modified by retroviral gene transfer to express the S-type and normal M-type human α1AT geens. Northern analysis and S1 protection analysis demonstrated that monocytes of M and S homozygotes both express 1.8-kilobase α1AT mRNA transcripts in comparable levels and similar in structure. Pulse-chase labeling studies demonstrated that both M and S monocytes synthesized and secreted a 52-kDa protein, but the S monocytes secreted significantly less. The cellular lysates of both M and S monocytes contained a newly synthesized 50-kDa precursor form of α1AT, but the S monocytes contained reduced amounts. Pulse-chase labeling in the presence of tunicamycin, an inhibitor of core oligosaccharide addition, demonstrated that S monocytes exhibited a selective inhibition of secretion of 45-kDa nonglycosylated α1AT not observed in M monocytes. Consistent with these observations, murine fibroblasts modified by retroviral gene transfer to contain as integrated human S-type α1AT cDNA demonstrated reduced secretion of α1AT compared with fibroblasts containing an integrated human M-type α1AT cDNA and also reproduced the abnormality of α1AT biosynthesis observed with S-type monocytes. Furthermore, in the presence of leupeptin, an inhibitor of cellular proteinases, the S-type modified fibroblasts demonstrated a selective augmentation of human α1AT secretion not observed for the M-type. Together, these observations are consistent with the concept that the single A → T mutation of the S-type α1AT gene results in reduced cellular secretion of α1AT because the newly synthesized S-type α1AT protein is degraded intracellularly prior to secretion.

UR - http://www.scopus.com/inward/record.url?scp=0024397003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024397003&partnerID=8YFLogxK

M3 - Article

C2 - 2567291

AN - SCOPUS:0024397003

VL - 264

SP - 10477

EP - 10486

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 18

ER -